JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Forman, H. J.
Right arrow Articles by Fisher, A. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Forman, H. J.
Right arrow Articles by Fisher, A. B.

Mechanism for the potentiation of oxygen toxicity by disulfiram

HJ Forman, JL York and AB Fisher

Rats given disulfiram (200 mg/kg) or diethyldithiocarbamate (200 mg/kg) by intraperitoneal injection were exposed to 2 atmospheres absolute oxygen in a hyperbaric chamber or kept in normoxia. By 12 hr of hyperoxia exposure, none of the control but 30% of the disulfiram- treated and 87% of the diethyldithiocarbamate-treated rats had died. Both disulfiram and diethyldithiocarbamate administration decreased lung cytosolic superoxide dismutase activity, but the pharmacokinetics were different. At 1 hr postinjection of diethyldithiocarbamate superoxide dismutase activity was 40% decreased but returned to control activity within 13 hr (4 hr, 18% inhibited). In contrast, disulfiram administration produced a greater decrease at 4 hr (31%) than at 1 hr (16%) and was still effective at 13 hr (28% less than control). Although disulfiram did not produce as great a decrease at 1 hr as did diethyldithiocarbamate, it's effect was more persistent. In vitro, diethyldithiocarbamate inactivated superoxide dismutase at 10(-4) M, although 10(-3) M disulfiram did not cause any reduction in enzymatic activity. The contrast between the inhibition by disulfiram of lung superoxide dismutase activity in vivo and its lack of effect in vitro suggests metabolism of disulfiram to diethyldithiocarbamate. It is likely that disulfiram administration potentiates oxygen toxicity via in vivo reduction to diethyldithiocarbamate and subsequent inhibition of superoxide dismutase.

Volume 212, Issue 3, pp. 452-455, 03/01/1980
Copyright © 1980 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 J. Immunol.Home page
M. Marikovsky, V. Ziv, N. Nevo, C. Harris-Cerruti, and O. Mahler
Cu/Zn Superoxide Dismutase Plays Important Role in Immune Response
J. Immunol., March 15, 2003; 170(6): 2993 - 3001.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
S. M. Deneke, P. H. Harford, K.-Y. Lee, C. F. Deneke, S. E. Wright, and S. G. Jenkinson
Induction of Cystine Transport and Other Stress Proteins by Disulfiram: Effects on Glutathione Levels in Cultured Cells
Am. J. Respir. Cell Mol. Biol., August 1, 1997; 17(2): 227 - 234.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
R. Pinkus, L. M. Weiner, and V. Daniel
Role of Oxidants and Antioxidants in the Induction of AP-1, NF-kappa B, and Glutathione S-Transferase Gene Expression
J. Biol. Chem., June 7, 1996; 271(23): 13422 - 13429.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
M. P. O'Meara
Ditiocarb Sodium and HIV Infection
JAMA, August 14, 1991; 266(6): 795 - 796.
[Abstract] [PDF]

Home page
 JAMAHome page
E. M. Hersh
Ditiocarb Sodium and HIV Infection
JAMA, August 14, 1991; 266(6): 796 - 796.
[Abstract] [PDF]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1980 by the American Society for Pharmacology and Experimental Therapeutics.